Skip to main content
NASDAQ:PSTX

Poseida Therapeutics News Headlines

$9.47
+0.63 (+7.13 %)
(As of 05/18/2021 10:13 AM ET)
Add
Compare
Today's Range
$9.37
$9.67
50-Day Range
$7.96
$10.07
52-Week Range
$7.63
$17.62
Volume1,713 shs
Average Volume336,620 shs
Market Capitalization$588.61 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Poseida Therapeutics (NASDAQ PSTX) News Headlines Today

SourceHeadline
Poseida Therapeutics (NASDAQ:PSTX) Receives New Coverage from Analysts at BTIG ResearchPoseida Therapeutics (NASDAQ:PSTX) Receives New Coverage from Analysts at BTIG Research
americanbankingnews.com - May 17 at 5:04 PM
Poseida Therapeutics, Inc. to Post Q2 2021 Earnings of ($0.64) Per Share, William Blair Forecasts (NASDAQ:PSTX)Poseida Therapeutics, Inc. to Post Q2 2021 Earnings of ($0.64) Per Share, William Blair Forecasts (NASDAQ:PSTX)
americanbankingnews.com - May 17 at 2:00 AM
Poseida Therapeutics (NASDAQ:PSTX) Posts Quarterly  Earnings ResultsPoseida Therapeutics (NASDAQ:PSTX) Posts Quarterly Earnings Results
americanbankingnews.com - May 12 at 6:58 PM
Critical Analysis: Poseida Therapeutics (NASDAQ:PSTX) & Orchard Therapeutics (NASDAQ:ORTX)Critical Analysis: Poseida Therapeutics (NASDAQ:PSTX) & Orchard Therapeutics (NASDAQ:ORTX)
americanbankingnews.com - May 12 at 1:16 PM
Poseida Therapeutics (NASDAQ:PSTX) Stock Price Up 7.5% After Better-Than-Expected EarningsPoseida Therapeutics (NASDAQ:PSTX) Stock Price Up 7.5% After Better-Than-Expected Earnings
americanbankingnews.com - May 12 at 12:16 PM
Poseida Therapeutics Reports Program Updates and Financial Results for the First Quarter 2021Poseida Therapeutics Reports Program Updates and Financial Results for the First Quarter 2021
finance.yahoo.com - May 11 at 6:12 PM
Poseida Therapeutics Presents Encouraging Preclinical Data Across its CAR-T and Gene Therapy Programs at the American Society of Gene and Cell Therapy 2021 Virtual Annual MeetingPoseida Therapeutics Presents Encouraging Preclinical Data Across its CAR-T and Gene Therapy Programs at the American Society of Gene and Cell Therapy 2021 Virtual Annual Meeting
finance.yahoo.com - May 11 at 1:11 PM
Poseida Therapeutics (NASDAQ:PSTX) Shares Gap Down to $8.66Poseida Therapeutics (NASDAQ:PSTX) Shares Gap Down to $8.66
americanbankingnews.com - May 10 at 4:38 PM
Poseida Therapeutics Announces Key Additions to Immuno-Oncology Scientific Advisory BoardPoseida Therapeutics Announces Key Additions to Immuno-Oncology Scientific Advisory Board
finance.yahoo.com - May 6 at 11:57 AM
Poseida Therapeutics, Inc. (NASDAQ:PSTX) CEO Eric Ostertag Sells 18,326 SharesPoseida Therapeutics, Inc. (NASDAQ:PSTX) CEO Eric Ostertag Sells 18,326 Shares
americanbankingnews.com - May 5 at 8:14 PM
Poseida Therapeutics to Present at BofA Securities 2021 Virtual Health Care ConferencePoseida Therapeutics to Present at BofA Securities 2021 Virtual Health Care Conference
finance.yahoo.com - May 5 at 12:17 PM
Poseida Therapeutics, Inc. (NASDAQ:PSTX) Short Interest Down 17.8% in AprilPoseida Therapeutics, Inc. (NASDAQ:PSTX) Short Interest Down 17.8% in April
americanbankingnews.com - May 3 at 2:14 AM
Read This Before Selling Poseida Therapeutics, Inc. (NASDAQ:PSTX) SharesRead This Before Selling Poseida Therapeutics, Inc. (NASDAQ:PSTX) Shares
finance.yahoo.com - April 28 at 1:08 PM
Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual MeetingPoseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting
finance.yahoo.com - April 27 at 8:06 PM
Matthew A. Spear Sells 4,000 Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) StockMatthew A. Spear Sells 4,000 Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) Stock
americanbankingnews.com - April 23 at 11:04 PM
Poseida Therapeutics (NASDAQ:PSTX) Shares Gap Up to $8.90Poseida Therapeutics (NASDAQ:PSTX) Shares Gap Up to $8.90
americanbankingnews.com - April 23 at 11:16 AM
Poseida Therapeutics to Present at Upcoming Virtual Investor ConferencesPoseida Therapeutics to Present at Upcoming Virtual Investor Conferences
finance.yahoo.com - April 8 at 9:45 AM
POSEIDA THERAP. DL-,0001 (2RZ.MU)POSEIDA THERAP. DL-,0001 (2RZ.MU)
sg.finance.yahoo.com - March 19 at 8:08 AM
Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020
finance.yahoo.com - March 11 at 5:27 PM
Why Poseida Therapeutics Stock Is Popping TodayWhy Poseida Therapeutics Stock Is Popping Today
finance.yahoo.com - February 24 at 1:45 PM
Poseida Therapeutics to Host Virtual R&D Day on February 24, 2021Poseida Therapeutics to Host Virtual R&D Day on February 24, 2021
finance.yahoo.com - February 10 at 11:18 AM
Poseida Therapeutics IncPoseida Therapeutics Inc
bloomberg.com - January 28 at 7:02 PM
What Percentage Of Poseida Therapeutics, Inc. (NASDAQ:PSTX) Shares Do Insiders Own?What Percentage Of Poseida Therapeutics, Inc. (NASDAQ:PSTX) Shares Do Insiders Own?
finance.yahoo.com - January 28 at 2:02 PM
IPO Lockup Expiration Alert: Poseida Therapeutics (PSTX)IPO Lockup Expiration Alert: Poseida Therapeutics (PSTX)
markets.businessinsider.com - January 6 at 2:39 AM
Poseida Therapeutics to Participate in SternIR Virtual Corporate Access EventPoseida Therapeutics to Participate in SternIR Virtual Corporate Access Event
finance.yahoo.com - January 4 at 12:50 PM
Poseida Therapeutics Added to NASDAQ Biotechnology IndexPoseida Therapeutics Added to NASDAQ Biotechnology Index
finance.yahoo.com - December 18 at 12:16 PM
Poseida Therapeutics Appoints Luke Corning to Board of DirectorsPoseida Therapeutics Appoints Luke Corning to Board of Directors
finance.yahoo.com - December 17 at 11:09 AM
Is PSTX A Good Stock To Buy Now?Is PSTX A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 11:19 PM
Poseida Therapeutics (PSTX) Presents At 62nd Virtual Annual Meeting of ASH - SlideshowPoseida Therapeutics (PSTX) Presents At 62nd Virtual Annual Meeting of ASH - Slideshow
seekingalpha.com - December 11 at 3:18 AM
Poseida Therapeutics EPS misses by $0.08Poseida Therapeutics EPS misses by $0.08
seekingalpha.com - November 12 at 7:40 PM
Poseida Therapeutics Reports Operational Update and Financial Results for Third Quarter 2020Poseida Therapeutics Reports Operational Update and Financial Results for Third Quarter 2020
finance.yahoo.com - November 12 at 7:40 PM
FDA lifts clinical hold on Poseidas prostate cancer cell therapy studyFDA lifts clinical hold on Poseida's prostate cancer cell therapy study
seekingalpha.com - November 2 at 8:37 AM
Poseida Therapeutics Announces Clinical Hold Lifted on Phase I Autologous CAR-T Study in Prostate CancerPoseida Therapeutics Announces Clinical Hold Lifted on Phase I Autologous CAR-T Study in Prostate Cancer
finance.yahoo.com - November 2 at 8:37 AM
Poseida Therapeutics inks license pact with TScan Therapeutics for COVID-19 therapiesPoseida Therapeutics inks license pact with TScan Therapeutics for COVID-19 therapies
seekingalpha.com - October 21 at 1:03 PM
Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19
finance.yahoo.com - October 21 at 1:03 PM
Poseida Therapeutics to join Russell 2000 indexPoseida Therapeutics to join Russell 2000 index
seekingalpha.com - September 18 at 9:28 AM
Poseida Therapeutics Added to Membership of US Small-Cap Russell 2000® IndexPoseida Therapeutics Added to Membership of US Small-Cap Russell 2000® Index
finance.yahoo.com - September 18 at 9:28 AM
Poseida Therapeutics to Present CAR-T Manufacturing Process Optimization Data at CAR-TCR Digital Week 2020Poseida Therapeutics to Present CAR-T Manufacturing Process Optimization Data at CAR-TCR Digital Week 2020
finance.yahoo.com - September 16 at 10:04 AM
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
finance.yahoo.com - September 4 at 2:23 PM
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmSHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
finance.yahoo.com - September 2 at 5:10 PM
POSEIDA THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Poseida Therapeutics, Inc. on Behalf of Poseida Stockholders and Encourages Investors to Contact the FirmPOSEIDA THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Poseida Therapeutics, Inc. on Behalf of Poseida Stockholders and Encourages Investors to Contact the Firm
finance.yahoo.com - September 1 at 6:38 PM
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmIMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
finance.yahoo.com - September 1 at 1:37 PM
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
finance.yahoo.com - August 31 at 12:34 PM
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmINVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
finance.yahoo.com - August 28 at 8:21 PM
Robbins LLP Is Investigating the Officers and Directors of Poseida Therapeutics, Inc. (PSTX) on Behalf of ShareholdersRobbins LLP Is Investigating the Officers and Directors of Poseida Therapeutics, Inc. (PSTX) on Behalf of Shareholders
finance.yahoo.com - August 24 at 8:06 PM
Poseida Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law FirmPoseida Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm
finance.yahoo.com - August 20 at 6:12 PM
Poseida Therapeutics Reports Operational Update and Financial Results for Second Quarter and First Half of 2020Poseida Therapeutics Reports Operational Update and Financial Results for Second Quarter and First Half of 2020
finance.yahoo.com - August 20 at 6:12 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Poseida Therapeutics, Inc. - PSTXSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Poseida Therapeutics, Inc. - PSTX
finance.yahoo.com - August 20 at 6:12 PM
Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Poseida Therapeutics, Inc. (PSTX) InvestigationBronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Poseida Therapeutics, Inc. (PSTX) Investigation
finance.yahoo.com - August 19 at 7:49 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Poseida Therapeutics, Inc. - PSTXSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Poseida Therapeutics, Inc. - PSTX
finance.yahoo.com - August 19 at 7:49 PM
This page was last updated on 5/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.